Lederer & Keller Patentanwalte Partnerschaft Mbb opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Lederer & Keller Patentanwalte Partnerschaft Mbb

Patent Number:
Title:
Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer
Opposition Date:
Jul 26, 2022
Patent Number:
Title:
Assays For Determining Plasma Kallikrein System Biomarkers
Applicant:
Opposition Date:
Jun 23, 2021
Patent Number:
Title:
Two-Phase Fermentation Process For The Production Of An Organic Compound
Applicant:
Opposition Date:
Jun 4, 2021
Patent Number:
Title:
Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect
Applicant:
Opposition Date:
May 3, 2021
Patent Number:
Title:
Compositions For Improving Cell Viability And Methods Of Use Thereof
Opposition Date:
Jan 12, 2021
Patent Number:
Title:
Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal Function
Opposition Date:
Dec 21, 2020
Patent Number:
Title:
Vilanterol Formulations
Opposition Date:
Oct 20, 2020
Patent Number:
Title:
Dry Powder Formulations Comprising Vilanterol
Opposition Date:
Oct 13, 2020
Patent Number:
Title:
Amorphous Lercanidipine Hydrochloride
Opposition Date:
Jul 8, 2020
Patent Number:
Title:
Particle Containing At Least A Volatile Substance And Process For Its Preparation
Opposition Date:
Jun 2, 2020

Competitors of Lederer & Keller Patentanwalte Partnerschaft Mbb

ARVEN ILAC SANAYI VE TICARET A.S.

DYAX CORP.

AMYLYX PHARMACEUTICALS INC.

Want to track Lederer & Keller Patentanwalte Partnerschaft Mbb?

Feel free to send us a message here and we will get back to you